Formulation of mayonnaise with the addition of a bioemulsifier isolated from Candida utilis.

Biosurfactants have a number of industrial applications due their diverse properties, such as emulsification, foaming, wetting, and surface activity. The aim of the present study was to produce a biosurfactant from Candida utilis and employ it in the formulation of a mayonnaise. The biosurfactant was produced in a mineral medium supplemented with glucose and canola waste frying oil at 150 rpm for 88 h. The product was biologically tested on rats and in different formulations of mayonnaise, which were submitted to microbiological evaluations. The biosurfactant was added to the diet of the rats for 21 days. Greater consumption was found of the experimental diet. Moreover, no changes were found in the liver or kidneys of the animals, demonstrating the absence of a toxic effect from the biosurfactant. Six different formulations of mayonnaise were prepared and tested regarding stability with the addition of carboxymethyl cellulose and guar gum (combined and isolated) after 30 days of refrigeration. The most stable formulation with the best quality was obtained with combination of guar gum and the isolated biosurfactant, with an absence of pathogenic microorganisms. In conclusion, the potential and innocuousness of the biosurfactant isolated from C. utilis indicates its safe use in food emulsions.

Production of a bioemulsifier with potential application in the food industry.

Biosurfactants are of considerable interest due to their biodegradability, low degree of toxicity, and diverse applications. However, the high production costs involved in the acquisition of biosurfactants underscore the need for optimization of the production process to enable viable application on an industrial scale. The aims of the present study were to select a species of Candida that produces a biosurfactant with the greatest emulsifying potential and to investigate the influence of components of the production medium and cultivation conditions. Candida utilis achieved the lowest surface tension (35.53 mN/m), best emulsification index (73%), and highest yield (12.52 g/l) in a medium containing waste canola frying oil as the carbon source and ammonium nitrate as the nitrogen source. The best combination of medium components and cultivation conditions was 6% (w/v) glucose, 6% (w/v) waste canola frying oil, 0.2% (w/v) ammonium nitrate, 0.3% (w/v) yeast extract, 150 rpm, 1% inoculum (w/v), and 88 h of fermentation. The greatest biosurfactant production and the lowest surface tension were achieved in the first 24 h of production, and the maximum biomass production was recorded at 72 h. The biosurfactant produced from C. utilis under the conditions investigated in the present study has a potential to be a bioemulsifier for application in the food industry.

Physico-chemical characteristics and functional properties of chitin and chitosan produced by Mucor circinelloides using yam bean as substrate.

Microbiological processes were used for chitin and chitosan production by Mucor circinelloides (UCP 050) grown in yam bean (Pachyrhizus erosus L. Urban) medium. The polysaccharides were extracted by alkali-acid treatment and structural investigations by X-ray diffraction, Fourier transform IR analysis, viscosity and thermal analysis by TG, DTG, and DTA were done. The highest biomass yield (20.7 g/L) was obtained at 96 hours. The highest levels of chitosan (64 mg/g) and chitin (500 mg/g) were produced at 48 and 72 hours, respectively. It was demonstrated that yam bean shows great potential as an economic medium and it is possible to achieve a good yield of chitosan with chemical properties that enable its use in biotechnological applications.

[Effect of vitamin E supplementation on alpha-tocopherol levels in human colostrum]. / Efeito da suplementação com vitamina E sobre a concentração de alfa-tocoferol no colostro humano.

OBJECTIVE: To assess the levels of alpha-tocopherol in human colostrum following supplementation with capsules containing vitamin A plus synthetic vitamin E. METHODS: Thirty healthy women about to give birth were recruited from a public maternity hospital. After overnight fasting, blood samples as well as colostrum samples (2 mL) were collected. After the first collection, the women received supplementation with a capsule containing retinyl palmitate (200,000 IU or 60 mg) plus synthetic vitamin E (49.4 mg dl-alpha tocopherol). Twenty-four hours after supplementation, a second 2 mL colostrum sample was collected after overnight fasting. RESULTS: The serum concentration of alpha-tocopherol was 1 042,9 ± 319.0 µg/dL. The concentration of alpha-tocopherol in colostrum before supplementation was 155.4 ± 811.0 µg/dL, vs. 1 396.3 ± 862.2 µg/dL 24 hours after supplementation (P > 0.05). A correlation was found between fasting levels of alpha-tocopherol in colostrum before supplementation and 24 hours after supplementation (P = 0.001; r = 0.58), but not between the concentrations in serum and colostrum. CONCLUSIONS: There was no increase in the levels of alpha-tocopherol in colostrum 24 hours after supplementation. This suggests that supplementation with synthetic vitamin E is not advantageous. However, the present results also suggest that if the nutritional state is adequate prior to supplementation, more tocopherol will be available in colostrum after supplementation. Further studies should be carried out to investigate the effects of supplementation with the natural form of alpha-tocopherol.

Efeito da suplementação com vitamina E sobre a concentração de alfa-tocoferol no colostro humano / Effect of vitamin E supplementation on alpha-tocopherol levels in human colostrum

OBJETIVO: Avaliar a concentração de alfa-tocoferol no colostro humano em condições de suplementação com cápsulas de vitamina A acrescidas de vitamina E sintética. MÉTODOS: Foram recrutadas para o estudo 30 parturientes saudáveis atendidas em uma maternidade pública. Após jejum noturno, foram coletadas amostras de sangue e de colostro (2 mL) das parturientes. Após a primeira coleta, as mesmas receberam suplemento na forma de uma cápsula de palmitato de retinila (200000 UI ou 60 mg) acrescido de vitamina E sintética (49,4 mg de dl-alfa-tocoferol). Após 24 horas da suplementação, foi realizada nova coleta de 2 mL de colostro, também em jejum. RESULTADOS: A concentração sérica de alfa-tocoferol foi de 1 042,9 ± 319,0 μg/dL. Os teores de alfa-tocoferol no colostro antes da suplementação foram de 1155,4 ± 811,0 μg/dL, vs. 1396,3 ± 862,2 μg/dL 24 horas depois da suplementação (P > 0,05). Foi encontrada correlação entre o alfa-tocoferol do colostro na condição de jejum antes da suplementação e 24 horas após a suplementação (P = 0,001; r = 0,58), mas não entre soro e o colostro em nenhuma das condições acima citadas. CONCLUSÕES: Não houve aumento na concentração de alfa-tocoferol do colostro 24 horas após a suplementação. Isso indica que não é vantajoso suplementar a mãe com vitamina E sintética. Entretanto, os resultados também sugerem que, se o estado nutricional prévio à suplementação estiver adequado, mais tocoferol será encontrado no colostro após a suplementação. Novos estudos devem ser realizados para investigar o efeito da suplementação com a forma natural do alfa-tocoferol.

OBJECTIVE: To assess the levels of alpha-tocopherol in human colostrum following supplementation with capsules containing vitamin A plus synthetic vitamin E. METHODS: Thirty healthy women about to give birth were recruited from a public maternity hospital. After overnight fasting, blood samples as well as colostrum samples (2 mL) were collected. After the first collection, the women received supplementation with a capsule containing retinyl palmitate (200 000 IU or 60 mg) plus synthetic vitamin E (49.4 mg dl-alpha tocopherol). Twenty-four hours after supplementation, a second 2 mL colostrum sample was collected after overnight fasting. RESULTS: The serum concentration of alpha-tocopherol was 1 042,9 ± 319.0 µg/dL. The concentration of alpha-tocopherol in colostrum before supplementation was 155.4 ± 811.0 µg/dL, vs. 1 396.3 ± 862.2 µg/dL 24 hours after supplementation (P > 0.05). A correlation was found between fasting levels of alpha-tocopherol in colostrum before supplementation and 24 hours after supplementation (P = 0.001; r = 0.58), but not between the concentrations in serum and colostrum. CONCLUSIONS: There was no increase in the levels of alpha-tocopherol in colostrum 24 hours after supplementation. This suggests that supplementation with synthetic vitamin E is not advantageous. However, the present results also suggest that if the nutritional state is adequate prior to supplementation, more tocopherol will be available in colostrum after supplementation. Further studies should be carried out to investigate the effects of supplementation with the natural form of alpha-tocopherol.

Vitamin E in human serum and colostrum under fasting and postprandial conditions.

OBJECTIVE: To evaluate alpha-tocopherol concentrations in maternal serum and colostrum under fasting and postprandial conditions. METHODS: Thirty healthy childbearing women were recruited in a public maternity hospital, and samples of blood, fasting colostrum, and postprandial colostrum were collected from them up to 12 hours after delivery. RESULTS: The serum alpha-tocopherol concentration was 1,939.8+/-766.0 microg/dL. Alpha-tocopherol levels in fasting colostrum (1,603.4+/-911.0 microg/dL) and in postprandial colostrum (1,515.0+/-890.9 microg/dL) did not demonstrate a statistically significant difference (p > 0.05). There was correlation between alpha-tocopherol levels in fasting and postprandial colostrum (p < 0.05), but not between serum and colostrum. CONCLUSION: The lack of correlation between alpha-tocopherol levels in plasma and in colostrum, and the correlation between alpha-tocopherol concentrations in fasting and postprandial colostrum support the existence of a mechanism that controls the transfer of this nutrient, regardless of dietary intake.

Vitamina E no soro e colostro humanos em condições de jejum e pós-prandial / Vitamin E in human serum and colostrum under fasting and postprandial conditions

OBJETIVO: Avaliar a concentração de alfa-tocoferol no soro e colostro maternos, seja em condições de jejum ou pós-prandial. MÉTODOS: Trinta parturientes saudáveis atendidas em uma maternidade pública foram recrutadas para o estudo, e amostras de sangue, colostro em jejum e colostro pós-prandial foram coletadas até 12 horas pós-parto. RESULTADOS: A concentração sérica de alfa-tocoferol foi de 1.939,8±766,0 μg/dL. O alfa-tocoferol no colostro em jejum, 1.603,4±911,0 μg/dL, e após a refeição, 1.515,0±890,9 μg/dL, não apresentaram diferença significativa (p > 0,05). Houve correlação entre o alfa-tocoferol do colostro na condição de jejum e no pós-prandial (p < 0,05), mas não entre o soro e o colostro. CONCLUSÃO: A falta de correlação entre o alfa-tocoferol no plasma e no colostro e a correlação entre o alfa-tocoferol no colostro em jejum e no pós-prandial reforçam a hipótese de um mecanismo de controle na passagem desse micronutriente, independente do aporte dietético.

OBJECTIVE: To evaluate alpha-tocopherol concentrations in maternal serum and colostrum under fasting and postprandial conditions. METHODS: Thirty healthy childbearing women were recruited in a public maternity hospital, and samples of blood, fasting colostrum, and postprandial colostrum were collected from them up to 12 hours after delivery. RESULTS: The serum alpha-tocopherol concentration was 1,939.8±766.0 μg/dL. Alpha-tocopherol levels in fasting colostrum (1,603.4±911.0 μg/dL) and in postprandial colostrum (1,515.0±890.9 μg/dL) did not demonstrate a statistically significant difference (p > 0.05). There was correlation between alpha-tocopherol levels in fasting and postprandial colostrum (p < 0.05), but not between serum and colostrum. CONCLUSION: The lack of correlation between alpha-tocopherol levels in plasma and in colostrum, and the correlation between alpha-tocopherol concentrations in fasting and postprandial colostrum support the existence of a mechanism that controls the transfer of this nutrient, regardless of dietary intake.

Potential of chitosan from Mucor rouxxi UCP064 as alternative natural compound to inhibit Listeria monocytogenes / Potencial de quitosana de Mucor rouxxi UCP 064 como componente alternativo para inibir Listeria monocytogenes

Listeria monocytogenes is widely distributed in nature and the infection listeriosis is recognized as a potential threat for human health because of its mortality rate. The objective of this study was to evaluate the growth profile and chitosan production by Mucor rouxxi UCP 064 grown in yam bean (Pachyrhizus erosus L. Urban) medium. It was also to assess the anti-L. monocytogenes efficacy of the obtained chitosan. Higher values of biomass of M. rouxxi (16.9 g.L¹) and best yield of chitosan (62 mg.g-1) were found after 48 h of cultivation. Residual glucose and nitrogen in the growth media were 4.1 and 0.02 g.L¹ after 96 h, respectively. Obtained chitosan presented 85 percent of degree of deacetylation and 2.60 x 10(4) g.mol-1of viscosimetric molecular weight. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) values of chitosan against L. monocytogenes ATCC 7644 were, respectively, 2.5 and 5.0 mg.mL-1. At 2.5 and 5.0 mg.mL-1 chitosan caused cidal effect in a maximum time of 4 h. Bacterial count below 2 log cfu.mL-1were found from 2 h onwards and no recovery in bacterial growth was noted in the remainder period. These results show the biotechnological potential of yam bean medium for chitosan production by Mucor rouxxi and support the possible rational use of chitosan from fungi as natural antimicrobial to control L. monocytogenes.

Listeria monocytogenes apresentase como um microrganismo amplamente distribuído na natureza, sendo que a infecção listeriose é reconhecida como uma potencial ameaça a saúde humana devido a sua taxa de mortalidade. O objetivo deste estudo foi avaliar o perfil de crescimento e de produção de quitosana por Mucor rouxxi UCP 064 cultivado em meio jacatupé (Pachyrhizus erosus L. Urban), bem como avaliar a eficácia anti-L. monocytogenes da quitosana produzida com vistas a uma possível aplicação em alimentos. Os mais elevados valores de biomassa de M. rouxxi (16,9 g.L¹) e o maior rendimento na produção de quitosana (62 mg.g-1) foram encontrados após 48 horas de cultivo. As quantidades residuais de glicose e nitrogênio no meio de crescimento após 96 horas foram 4,1 e 0,02 g.L¹ , respectivamente. A quitosana obtida apresentou grau de deacetilação de 85 por cento e peso molecular de 2,6 x 10(4) g.mol-1. Os valores da Concentração Inibitória Mínima (CIM) e Concentração Bactericida Mínima (CBM) da quitosana sobre L. monocytogenes ATCC 7664 foram, respectivamente, 2,5 e 5,0 mg.mL-1. Nas concentrações de 2,5 e 5,0 mg.mL-1a quitosana fúngica causou um efeito bactericida em um tempo máximo de 4 horas. Valores de contagens menores que 2 log ufc.mL-1foram encontrados a partir de 2 horas, sendo que nenhuma recuperação no crescimento bacteriano foi encontrado até 96 horas. Estes resultados mostram o potencial biotecnológico do meio jacatupé para produção de quitosana por Mucor rouxxi, bem como suportam o possível uso racional de quitosana fúngica como antimicrobiano natural para controlar o crescimento de L. monocytogenes.

Potential of chitosan from Mucor rouxxi UCP064 as alternative natural compound to inhibit Listeria monocytogenes.

Listeria monocytogenes is widely distributed in nature and the infection listeriosis is recognized as a potential threat for human health because of its mortality rate. The objective of this study was to evaluate the growth profile and chitosan production by Mucor rouxxi UCP 064 grown in yam bean (Pachyrhizus erosus L. Urban) medium. It was also to assess the anti-L. monocytogenes efficacy of the obtained chitosan. Higher values of biomass of M. rouxxi (16.9 g.L(-1)) and best yield of chitosan (62 mg.g(-1)) were found after 48 h of cultivation. Residual glucose and nitrogen in the growth media were 4.1 and 0.02 g.L(-1) after 96 h, respectively. Obtained chitosan presented 85 % of degree of deacetylation and 2.60 x 10(4) g.mol(-1) of viscosimetric molecular weight. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) values of chitosan against L. monocytogenes ATCC 7644 were, respectively, 2.5 and 5.0 mg.mL(-1). At 2.5 and 5.0 mg.mL(-1) chitosan caused cidal effect in a maximum time of 4 h. Bacterial count below 2 log cfu.mL(-1) were found from 2 h onwards and no recovery in bacterial growth was noted in the remainder period. These results show the biotechnological potential of yam bean medium for chitosan production by Mucor rouxxi and support the possible rational use of chitosan from fungi as natural antimicrobial to control L. monocytogenes.

Staphylococcal toxin genes in strains isolated from cows with subclinical mastitis / Detecção de genes de toxinas em linhagens de estafilococos isolados de vacas com mastite subclínica

The present study was carried out in 11 dairy herds in four municipal districts of the rural area of the State of Pernambuco, Brazil. Out of 984 quarter milk (246 cows), 10 (1.0%) were positive for clinical mastitis, 562 (57.1%) for subclinical mastitis and 412 (41.9%) were negative. A total of 81 Staphylococcus spp. isolates were obtained from milk samples from the cows diagnosed with subclinical mastitis. From these, 53 (65.0%) were S. aureus, 16 (20.0%) coagulase-positive staphylococci (CPS) and 12 (15.0%) coagulase-negative staphylococci (CNS). The isolates were further investigated for the presence of toxin genes by multiplex and uniplex PCR. The main gene observed was seg followed by seh, sei and sej. The distribution of these observed genes among the isolates obtained from different areas showed a regional pattern for the SEs. The presence of toxin genes in the strains isolated from bovine milk demonstrates a potential problem for public health.(AU)

O presente estudo foi realizado em 11 rebanhos leiteiros de quatro municípios da área rural do estado de Pernambuco, Brasil. Dos 984 quartos mamários examinados (246 vacas), 10 (1,0%) foram positivos para a mastite clínica, 562 (57,1%) para a mastite subclínica e 412 (41,9%) foram negativos para mastite. Foram isoladas 81 linhagens de Staphylococcus spp. do leite de vacas com mastite subclínica. Destes, 53 (65,0%) foram S. aureus, 16 (20,0%) estafilococos coagulase-positivo (SCP) e 12 (15,0%) estafilococos coagulase-negativo (SCN). O principal gene observado nos estafilococos foi o seg seguido pelo seh, sei e sej. Foi constatada distribuição regional dos genes dos estafilococos isolados dos animais nos municípios estudados. A presença dos genes das toxinas nas linhagens isoladas do leite de vacas representa risco potencial para a Saúde Pública.(AU)

Pesquisa micotoxológica de produtos avícolas " in natura " e processados / Mycotoxicological research of poultry

Analisou-se a ocorrência de aflatoxinas e ocratoxina A em carcaças, vísceras comestíveis e processadas de aves de empresas que representam diferentes regiões de produção avícola do Brasil. Diferentes tipos de produtos foram coletados trimestralmente, sendo nove " in natura" e oito processados para extração de micotoxinas e quantificação pelo ensaio imunoenzimático (ELISA). Amostras positivas pelo método ELISA foram analisadas por cromatrografia em camada delgada (CCD). Do total de amostras analisadas 12 por cento foram positivas, sendo 10,8 opr cento para aflatoxina total e 1,2 por cento para ocratoxina A. Os resultados obtidos pela CCD mostraram contaminação por aflatoxinas (B1, B2, G, G2) em concentração inferior a 5 ug/kg. O ensaio imunoenzimático (ELISA) mostrou-se mais eficaz para produtos " in natura" , sendo isolada maior quantidade de aflatoxinas e ocratoxina A no segundo trimestre (julho-setembro). A ocorrência de aflatoxina total foi mais frequente em produtos oriundos das empresas avícolas das diferentes regiões do estado de Pernambuco e ocratoxina A das empresas produtoras das Regiões Sul e Sudeste do Brasil